Methods: A consecutive 117 patients (mean age, 71 6 8 years; 95 men) undergoing IAAA repair between 2004 and 2016 were included. Primary outcomes were all-cause mortality and AAA-related mortality. Freedom from reintervention, presence of hydronephrosis (HF) caused by perianeurysmal fibrosis, and renal insufficiency (defined as absolute serum creatinine value >2 mg/dL or an increased value >0.5 mg/dL vs the baseline one) before and after repair at the last follow-up were considered secondary end points. EVAR was performed according to the instructions for use of each device.
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Objective: Endovascular repair of complex abdominal aortic aneurysms (AAAs) has become increasingly common, but reports have been mostly limited to single-center and single-device studies.
Methods: We studied all endovascular repairs of complex AAA (zone 6 or caudal) from 2012 to 2017 in the Vascular Quality Initiative. This included all fenestrated, branched, and snorkel/chimney repairs composed of off-the-shelf, custom-manufactured, and physician-modified devices.
Results: There were 1663 complex endovascular repairs; 1534 (92%) were performed electively, 83 (5%) were symptomatic, and 45 (3%) were ruptured. The average age was 74 (6 8) years; 22% were female, and 87% were white. There were 604 off-the-shelf fenestrated devices, 673 custom-manufactured grafts, 189 physician-modified devices, and 197 chimney/snorkels. There were 4958 renal-visceral vessels intervened on: 391 (24%) repairs involving two vessels, 646 (39%) three vessels, and 557 (33%) four vessels, with a median of three (interquartile range, two to four). The number of centers contributing complex repairs expanded from 2 centers in 2 regions in 2012 to 81 centers from 17 regions in 2017. The number of repairs increased steadily from 5 in 2012 to 525 in 2016. Eleven percent of patients had prior AAA repairs. The rate of perioperative death was 3.5% for elective cases, 6% for symptomatic, and 22% for ruptures, with no significant change over time and no difference based on repair type. The overall perioperative complication rate was 29%. By RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage) criteria, 309 patients (19%) experienced acute kidney injury: risk, 98 (6%); injury, 76 (5%); failure, 85 (5%); loss of function (temporary dialysis), 21 (1.3%); endstage renal disease, 29 (2%). Twelve patients (0.7%) underwent open conversion during the index hospitalization. There were 46 (3%) patients with mesenteric ischemia, 19 of whom (1%) underwent bowel resections. Sixteen patients (1%) experienced strokes, 4 patients (0.2%) suffered transient ischemic attacks, and 60 patients (4%) had myocardial infarctions. There were 62 patients reintubated after the initial procedure (4%), and 109 patients (7%) had access site complications. During the index hospitalization, 75 patients (5%) underwent reinterventions related to their aneurysm, and 10 (1%) underwent unrelated operations. The 1-, 2-, and 3-year mortality rates were 91%, 89%, and 88%, respectively, with no significant difference by device type (P ¼ .30).
Conclusions: Complex endovascular repair is becoming increasingly common, both in the number of operations and in the number of centers and regions in which they occur. Rates of perioperative morbidity and mortality as well as 2-year survival are acceptable, but further study is needed to establish the durability of these novel technologies.
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Outcomes Objective: The Cook Zenith fenestrated endovascular graft (ZFEN; Cook Medical, Bloomington, Ind) is the only commercially available graft in the United States. Fenestrated endograft technology has been widely accepted as a safe and effective technique to treat more complex abdominal aortic aneurysm anatomy. Data suggest that most centers do only a small volume of cases, despite widespread training of surgeons on the procedure. We reviewed the first 100 consecutive ZFEN endografts performed at our center to evaluate this technology.
Methods: A prospectively maintained database of all aortic aneurysm repairs was queried for all fenestrated endovascular aneurysm repairs (FEVARs) performed since July 2013. Demographic data were obtained in addition to aortic anatomic characteristics, periprocedural details (radiation dose available after June 2015), and postoperative outcomes. Statistical analysis was performed with the SAS software package (SAS Institute, Cary, NC).
Results: There were 100 FEVARs performed from July 2013 to June 2017 (80% male; mean age, 73 6 8.1 years). Two surgeons performed 92% of cases. All cases were elective; 91 were performed for aneurysm disease (28% juxtarenal, 63% pararenal), and 9 were performed for type I endoleaks. There was a 98% aneurysm exclusion rate with 264 vessels cannulated through 272 fenestrations (97% technical success). Graft configurations include 2 with one fenestration, 18 with two fenestrations, 2 with three fenestrations, 5 with a scallop and one fenestration, and 73 with a scallop and two fenestrations. Mean operative time was 224.4 6 72.1 minutes with a blood loss of 508.2 6 561.0 mL. Mean fluoroscopy time was 64.8 6 25.9 minutes with a radiation dose of 966.5 6 652.6 Gy/cm 2 and 116.3 6 41.4 mL iodinated contrast material. There was no difference in operative time, blood loss, or mean fluoroscopy time between the first 50 and last 50 cases. Mean contrast material volume decreased by 14% from 125 mL to 107 mL (P ¼ .02). The 30-day morbidity includes myocardial infarction (2%), arrhythmia (3%), reintubation (2%), gastrointestinal ischemia (3%), and stroke (1%). There were three perioperative deaths due to decompensated cirrhosis, mesenteric ischemia, and cardiopulmonary arrest, respectively. At an average follow-up of 1.0 6 1.0 years, there were no aneurysm-related deaths with four branch stent thromboses (99% patency) and 91% freedom from endoleak. Reintervention was required in 18 patients, most often for branch vessel kinking (4), endoleak (4), mesenteric ischemia (3), access-related complications (3), and stent maldeployment or thrombosis (2).
Conclusions: Despite the complexity and associated risks of FEVAR, outcomes at a high-volume center demonstrate acceptable morbidity and freedom from branch occlusion and endoleaks. 
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Acute and Chronic Renal Dysfunction After Open and Endovascular Abdominal Aortic Aneurysm Repair
Brandon Van Asseldonk, Ahmed J. Elzahabi, Janice Montbriand, Naomi Eisenberg, Graham Roche-Nagle. University of Toronto, Toronto, Ontario, Canada
Objective: Abdominal aortic aneurysms remain an important health problem specifically for men older than 65 years. Distinct aspects of both endovascular aneurysm repair (EVAR) and open repair place patients at risk for renal dysfunction in the short and long term. Kidney injuries increase the risk of postoperative morbidity, mortality, and prolonged hospital stay. This study analyzed the incidence of acute and chronic renal dysfunction as well as contributing factors in patients after abdominal aortic aneurysm repair.
Methods: Retrospective chart review of patients who underwent either open or endovascular repair of abdominal aortic aneurysm at Toronto General Hospital from August 1, 2010, to June 30, 2016, yielded 587 patients from the Vascular Quality Initiative database. Demographics, comorbidities, operative details, and preoperative and follow-up creatinine values were obtained for patients by electronic medical records.
Results: Of the population of patients generated from chart review (n ¼ 587), a total of 521 remained after application of exclusion criteria, which included preoperative dialysis or kidney transplantation, postoperative creatinine values within 90 days of repair, or any absent primary outcome. The open and endovascular repair groups consisted of 149 (28.6%) and 372 (63.4%) patients, respectively. The majority of patients were male (82.7%), and the mean age was 78.8 years in the EVAR group and 71.5 years in the open group (t ¼ 9.9; P < .0002). Group comparison is included in the 
